Worth Asset Management LLC Buys 22,407 Shares of SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 525.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 26,672 shares of the exchange traded fund’s stock after purchasing an additional 22,407 shares during the quarter. SPDR S&P Biotech ETF makes up approximately 1.4% of Worth Asset Management LLC’s investment portfolio, making the stock its 15th biggest position. Worth Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $3,252,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of XBI. AQR Capital Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after buying an additional 2,167 shares during the period. Global Retirement Partners LLC bought a new position in SPDR S&P Biotech ETF in the second quarter valued at about $524,000. Johnson Financial Group Inc. acquired a new stake in SPDR S&P Biotech ETF in the second quarter worth about $31,000. Scotia Capital Inc. increased its position in SPDR S&P Biotech ETF by 3.9% in the second quarter. Scotia Capital Inc. now owns 38,969 shares of the exchange traded fund’s stock worth $3,231,000 after purchasing an additional 1,450 shares during the period. Finally, Pursue Wealth Partners LLC raised its holdings in SPDR S&P Biotech ETF by 4.9% during the 2nd quarter. Pursue Wealth Partners LLC now owns 11,485 shares of the exchange traded fund’s stock worth $952,000 after purchasing an additional 537 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 3.5%

Shares of NYSEARCA:XBI opened at $119.59 on Friday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $132.09. The stock has a market capitalization of $7.99 billion, a P/E ratio of 11.47 and a beta of 0.93. The business has a 50-day moving average price of $125.08 and a two-hundred day moving average price of $117.25.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.